United Therapeutics Corp Community Page | What other sites are saying about United Therapeutics Corp

United Therapeutics Corp

(NQ: UTHR)

69.17 USD +0.69 (+1.01%)

Official Closing Price / Updated: 8:10 PM EDT, May 17, 2013 / Add to My Watchlist

(UTHR) Community Analysis from

READ MORE (UTHR)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 19, 2013

(UTHR) United Therapeutics Corporation to Move Pluristem Therapeutics Drug into Phase I

(Stock Blog Hub, 4/21/13)

United Therapeutics Corporation (UTHR) recently gained approval for the commencement of a phase I study in Australia using Pluristem...(read more)

(UTHR) United Therapeutics Reiterated at Neutral

(Stock Blog Hub, 1/2/13)

We recently reiterated a Neutral recommendation on United Therapeutics (UTHR). While the company reported strong third-quarter results, United Therapeutics suffered a major...(read more)

Biotech Value Stock Pick

(Invest2Success, 10/15/12)

> This Weeks Value Stock Pick - United Therapeutics Zacks Investment Research reports United Therapeutics Corporation (UTHR) performed above expectations in the first half of 2012 and is positioned...(read more)

View all posts about United Therapeutics (UTHR)

United Therapeutics (UTHR) Company Overview

There is no analysis for UTHR yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates